SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001288123-11-000037
Filing Date
2011-04-28
Accepted
2011-04-28 12:19:20
Documents
1
Period of Report
2011-04-26
Filing Date Changed
2011-04-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3197
  Complete submission text file 0001288123-11-000037.txt   4645
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O ANTIGENICS INC. 3 FORBES RD LEXINGTON MA 02421
Business Address
Valentine Karen (Reporting) CIK: 0001437152 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 11786673